Immunization, HepB3 in OECD members
OECD members: Immunization, HepB3 was 89.3% in 2024. ◆ Volatile
Immunization, HepB3 in OECD members, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in OECD members is 89.3%, measured in 2024.
Compared with earlier readings it is down 1.2% on the previous year and up 15.6% over ten years.
Over the whole period, immunization, hepb3 in OECD members peaked at 90.4% in 2023 and was at its lowest, 0.0%, in 1985.
That places OECD members 12th out of 45 groups with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in OECD members, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 3.2% | — |
| 1992 | 3.9% | +21.6% |
| 1993 | 8.5% | +117.8% |
| 1994 | 15.6% | +84.0% |
| 1995 | 30.8% | +97.5% |
| 1996 | 38.5% | +24.9% |
| 1997 | 40.7% | +5.8% |
| 1998 | 43.0% | +5.7% |
| 1999 | 43.9% | +2.0% |
| 2000 | 65.0% | +48.1% |
| 2001 | 67.3% | +3.5% |
| 2002 | 67.7% | +0.6% |
| 2003 | 69.7% | +2.9% |
| 2004 | 71.1% | +2.1% |
| 2005 | 72.6% | +2.1% |
| 2006 | 74.0% | +1.9% |
| 2007 | 75.0% | +1.3% |
| 2008 | 75.4% | +0.5% |
| 2009 | 75.2% | -0.3% |
| 2010 | 75.9% | +1.0% |
| 2011 | 77.8% | +2.4% |
| 2012 | 78.1% | +0.4% |
| 2013 | 75.7% | -3.1% |
| 2014 | 77.2% | +2.1% |
| 2015 | 77.0% | -0.3% |
| 2016 | 78.5% | +2.0% |
| 2017 | 75.1% | -4.4% |
| 2018 | 75.0% | -0.1% |
| 2019 | 86.7% | +15.5% |
| 2020 | 88.8% | +2.4% |
| 2021 | 89.4% | +0.7% |
| 2022 | 90.0% | +0.7% |
| 2023 | 90.4% | +0.3% |
| 2024 | 89.3% | -1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 22.8% | 0.0% | 43.9% | 10 |
| 2000s | 71.3% | 65.0% | 75.4% | 10 |
| 2010s | 77.7% | 75.0% | 86.7% | 10 |
| 2020s | 89.6% | 88.8% | 90.4% | 5 |
More health data for OECD members
- Population ages 80 and above, female, per capita 0.031 units per person (2025)
- Population ages 80 and above, male, per capita 0.0197 units per person (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 80 and above, male, annual growth rate 2.77 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0174 units per person (2025)
- Population ages 80 and above, female, annual growth rate 1.95 % change on previous year (2025)
- Population ages 75-79, female, annual growth rate 4.66 % change on previous year (2025)
- Population ages 80 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in OECD members?
- Immunization, hepb3 in OECD members was 89.3% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in OECD members?
- The highest recorded value was 90.4% in 2023.
- What is the lowest immunization, hepb3 recorded in OECD members?
- The lowest recorded value was 0.0% in 1985.
- How does OECD members rank for immunization, hepb3?
- OECD members ranks 12th out of 45 groups with data for 2024.
- Is immunization, hepb3 rising or falling in OECD members?
- Over the last ten years it is up 15.6%. The long-run trend across the full record is volatile.
- Where does this OECD members data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.